Key Insights

Highlights

Success Rate

78% trial completion

Published Results

16 trials with published results (31%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

17.6%

9 terminated out of 51 trials

Success Rate

77.5%

-9.0% vs benchmark

Late-Stage Pipeline

24%

12 trials in Phase 3/4

Results Transparency

52%

16 of 31 completed with results

Key Signals

16 with results78% success

Data Visualizations

Phase Distribution

39Total
Not Applicable (21)
P 1 (2)
P 2 (4)
P 3 (6)
P 4 (6)

Trial Status

Completed31
Terminated9
Unknown7
Withdrawn2
Active Not Recruiting1
Recruiting1

Trial Success Rate

77.5%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT04798768Not ApplicableActive Not RecruitingPrimary

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing

NCT05765175Not ApplicableRecruitingPrimary

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

NCT02235545Terminated

Optisure Lead Post Approval Study

NCT00147277Phase 4CompletedPrimary

ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy

NCT00170287Phase 4CompletedPrimary

SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)

NCT00147290Phase 4CompletedPrimary

ADVANCE CRT - D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy

NCT01085435CompletedPrimary

Boston Scientific Post Market Subcutaneous-Implantable Cardioverter Defibrillator (S-ICD) Registry

NCT05086510Not ApplicableCompletedPrimary

Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping

NCT02661048Not ApplicableCompletedPrimary

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

NCT04983797Not ApplicableCompleted

A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter

NCT04075253Not ApplicableCompletedPrimary

Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia

NCT04070300Not ApplicableCompletedPrimary

Physical Activity and Ventricular Arrhythmias

NCT05676398Unknown

Cardiac Arrhythmias at Extreme Altitude

NCT04208997Phase 3TerminatedPrimary

Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation

NCT02637947Not ApplicableTerminatedPrimary

Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population

NCT04334811Not ApplicableWithdrawnPrimary

Stereotactic Ablative Radiotherapy (SAbR) for Treatment of Ventricular Tachycardia (VT) Refractory Standard Invasive Ablation Techniques

NCT04919733Not ApplicableUnknown

Fluoroscopy Reduction or Elimination in CIED Implants

NCT02994446Not ApplicableCompletedPrimary

Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia

NCT02072707Not ApplicableCompletedPrimary

Efficacy and Safety of Epicardial VT Ablation Using Contact Force Irrigated Tip Catheter - Pilot Study

NCT01940081Completed

The Leiden Nonischemic Cardiomyopathy Study

Scroll to load more

Research Network

Activity Timeline